DOCSLIB.ORG

Basic Reading List (Page 4) Advanced Reading List 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Basic Reading List (Page 4) Advanced Reading List 1 PSYCHIATRY OF LEARNING DISABILITY- READING LIST PSYCHIATRY OF LEARNING DISABILITY- READING LIST CONTENTS Preface (page 3) Basic Reading List (page 4) Advanced Reading List 1. Diagnostic Assessment & Epidemiology (page 5) 2. Challenging Behaviour (page 6) 3. Psychosis and Mood disorders (page 8) 4. Dementia & Aging (page 10) 5. Personality Disorders (page 12) 6. Substance Misuse (page 16) 7. Epilepsy (page 18) 8. Forensic Learning Disability (page 20) 9. Autistic Spectrum Disorders (page 28) 10. ADHD (page 30) 11. Psychopharmacology (page 33) 12. Psychotherapy (page 37) 13. Consent & Capacity Issues (page 41) 14. Service Provision (page 44) 15. Physical Healthcare (page 47) 1 PREFACE This list was put together with contributions from Dr Miriam Isaac (Speciality Registrar), Dr Kerstin Stueber (Speciality Registrar), Dr Vishwa Radhakrishnan (Speciality Registrar), Dr Fola Esan (Consultant Psychiatrist) and Ms Verity Chester (Research Assistant). Ms Nicole Reavell provided secretarial assistance. Dr Angela Hassiotis (Reader, UCL & Consultant Psychiatrist) co-ordinated the process with me. It includes a basic reading list which provides a brief introduction to the area of mental health in people with intellectual disabilities and an advanced reading list which is organised under 15 separate subject areas. There is considerable overlap between some of these subject areas and you may have to look at related headings for a full list of the relevant material. The references are arranged in chronological order with the most recent coming first. This list is by no means comprehensive and it would be best to consider this very much as a work in progress. I will of course be delighted to receive any suggestions from you on [email protected] about any other references that can be added to this list. Dr Regi T Alexander, Academic Secretary Faculty of Psychiatry of Learning Disability, Royal College of Psychiatrists 23 September 2011 2 BASIC READING LIST Companion to Psychiatric Studies, pages 541-594, Churchill Livingstone 2010. Intellectual Disability Psychiatry: A Practical Handbook. Edited by Angela Hassiotis, Diana Andrea Barron and Ian Hall.(2010) Wiley Publications. Psychiatric and Behavioural Disorders in Intellectual and Developmental Disabilities (Second Edition 2007). Edited by Nick Bouras and Geraldine Holt (2007) Cambridge University Press Handbook of intellectual and developmental disabilities. W. Jacobson, J. A. Mulick & J. Rojahn (Eds.), 2007 New York: Springer Publishing Co. The Psychiatry of Intellectual Disability. Edited by Meera Roy, Ashok Roy & David Clark. 2006 Radcliffe Publishing Ltd. Guide to Mental Health for Families and Carers of People with Intellectual Disabilities (2004). Edited by Geraldine Holt, Anastasia Gratsa, Nick Bouras et al. Jessica Kingsley Publications. Seminars in the Psychiatry of Learning Disabilities (Second edition). Edited by William Fraser and Michael Kerr (2003) Royal College of Psychiatrists Publications. 3 ADVANCED READING LIST 1. DIAGNOSTIC ASSESSMENT & EPIDEMIOLOGY Books/ Reports: Royal College of Psychiatrists. DC-LD: Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/mental Retardation (Occasional paper) http://www.rcpsych.ac.uk/publications/collegereports/op/op48.aspx Diagnostic Manual-Intellectual Disabilities (DM-ID): A Textbook of Diagnosis of Mental Disorders in People with Intellectual Disability http://www.dmid.org/ Journal articles: Cooper, S.-A., van der Speck, R. (2009) Epidemiology of mental ill health in adults with intellectual disabilities. Current Opinion in Psychiatry. 22: 431-436. Smiley, E., Cooper, S-A., Finlayson, J., Jackson, A., Allan, L., Mantry, D., McGrother, C., McConnachie, A., Morrison, J. (2007) The incidence, and predictors of mental ill-health in adults with intellectual disabilities. Prospective study. British Journal of Psychiatry, 191: 313-319. Cooper, A., Simpson, N. (2006). Assessment and classification of psychiatric disorders in adults with learning disabilities. Psychiatry, 5: 306-11. The Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD) papers. Journal of Intellectual Disability Research, 47, Supplement 1-2 (2003). 4 2. CHALLENGING BEHAVIOUR Books / Reports: Emerson, E., Einfeld, S. (2011) Challenging Behaviour. 3rd Edition. Cambridge University Press The Frith Prescribing Guidelines: For Adults with Intellectual Disability' (Eds. S. Bhaumik & D. Branford), HealthComm. UK Ltd., Aberdeen (2008). Royal College of Psychiatrists (2007). Challenging Behaviour: a unified approach. CR 144 http://www.rcpsych.ac.uk/files/pdfversion/cr144.pdf Services For People With Learning Disabilities And Challenging Behaviour Or Mental Health Needs (revised edition) (2007) http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAn dGuidance/DH_080129 Journal articles Willner, P., Jahoda, A., Rose, J., Stenfert-Kroese, B., Hood, K., Townson, J.K., Nuttall, J., Gillespie, D., Felce, D. (2011). Anger management for people with mild to moderate learning disabilities: Study protocol for a multi-centre cluster randomized controlled trial of a manualized intervention delivered by day-service staff. Trials 2011, 12:36 http://www.trialsjournal.com/content/pdf/1745-6215-12-36.pdf H ßler, F. & Reis, O. (2010). Pharmacotherapy of disruptive behavior in mentally retarded subjects: A review of the current literature. Developmental Disabilities Research Reviews, 16 (3) 265-72. http://onlinelibrary.wiley.com/doi/10.1002/ddrr.119/abstract Tsiouris, J. A. (2010). Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment. Journal of Intellectual Disability Research, 54 (1) 1-16. http://www.ncbi.nlm.nih.gov/pubmed/20122096 Tyrer, P., Oliver-Africano, P., Romeo, R., Knapp, M., Dickens, S., Bouras, N., et al. Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID) (2009). Health Technology Assessment; 13(21): 1-76. http://www.library.nhs.uk/LEARNINGDISABILITIES/ViewResource.aspx?resID=3 29178 Hassiotis, A., Robotham, D., Canagasabey, A., Romeo, R., Langridge, D., Blizard, R., Murad, S., King, M. (2009). Randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities. 5 American Journal of Psychiatry, 166(11), 1278 – 1285. doi:10.1176/appi.ajp.2009.08111747 Antonacci, D.J., Manuel, C. & Davis, E. (2008). Diagnosis and Treatment of Aggression in Individuals with Developmental Disabilities. Psychiatric Quarterly, 79 (3) 225-247. http://www.springerlink.com/content/513t115q11655531/ Journal of Applied Research in Intellectual Disabilities, Supplement on Positive Behaviour Support (2007) Volume 20, Issue 1. Knapp, M., Comas-Herrera, A., Astin, J., Beecham, J., Pendaries, C. (2005). Intellectual disability, challenging behaviour and cost in care accommodation: what are the links? Health & Social Care in the Community,13(4): 297–306. http://eprints.lse.ac.uk/336/1/dp1930.pdf 6 3. PSYCHOSIS & MOOD DISORDERS Journal Articles Reviews Hemmings, C. P. (2006) Schizophrenia spectrum disorders in people with intellectual disabilities. Current Opinion Psychiatry. 19(5):470-4. Review. Prevalence/ Epidemiology Reid, K. A., Smiley, E., Cooper, S.-A. (2011) Prevalence and associations of anxiety disorders in adults with intellectual disabilities. Journal of Intellectual Disability Research. 55: 172-181. Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study. British Journal of Psychiatry 2008, 193: 364 - 372. Cooper, S. A., Smiley, E., Morrison, J., Allan, L., Williamson, A., Finlayson, J., Jackson, A., Mantry, D. (2007) Psychosis and adults with intellectual disabilities. Prevalence, incidence, and related factors. Social Psychiatry and Psychiatric Epidemiology. 42(7):530-6. Cooper, S.A., Smiley, E., Morrison, J., Williamson, A., Allan, L. (2007) An epidemiological investigation of affective disorders with a population-based cohort of 1023 adults with intellectual disabilities. Psychological Medicine 37(6):873-82. Greenwood, C.M., Husted, J., Bomba, M.D., Hodgkinson, K. A., Bassett, A.S. (2004) Elevated rates of schizophrenia in a familial sample with mental illness and intellectual disability. Journal Intellectual Disability Research. 48:531-9. Bouras, N., Martin, G., Leese, M., Vanstraelen, M., Holt, G., Thomas, C., Hindler, C., Boardman, J. (2004) Schizophrenia-spectrum psychoses in people with and without intellectual disability. Journal of Intellectual Disability Research. 48:548-55. Diagnosis & Treatment Sturmey, P., Laud, R. B., Cooper, C.L., Matson, J.L., Fodstad, J.C. (2010) Mania and behavioral equivalents: a preliminary study. Research in Developmental Disabilities. 31(5):1008-14. Hassiotis, A., Serfaty, M., Azam, K., Strydom, A., Martin, S., Parkes, C., Blizard, R., King, M.. (2010) Cognitive behaviour therapy (CBT) for anxiety and depression in adults with mild intellectual disabilities (ID): a pilot randomised controlled trial. Trials 12:95. 7 Perez-Achiaga, N., Nelson, S., Hassiotis, A. (2009) Instruments for the detection of depressive symptoms in people with intellectual disabilities: a systematic review. Journal of Intellectual Disability 13 (1): 55-76. Lindsay, W., Skene, D. (2007) The Beck Depression Inventory II and the Beck Anxiety Inventory in people with intellectual
Load more

Recommended publications
  • Scientific Program 12
    1 2 3 CONGRESS CHAIRMEN Dafin F. Mureşanu Chairman and Professor of Neurology, Department of Neurology, University CFR Hospital, Cluj-Napoca, Romania Vice Dean of the Faculty of Medicine, “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN) Natan M. Bornstein Professor of Neurology at the Tel-Aviv University Sackler Faculty of Medicine, Israel Vice President of the World Stroke Organization (WSO) Head of Stroke Unit at the Tel-Aviv Medical Center Chairman of the Israeli Neurological Association 4 FACULTY /in alphabetical order Anton Alvarez / Spain Volker Hömberg / Germany Russell J. Andrews / USA Amos Korczyn / Israel Raul Arizaga / Argentina Boris Kotchoubey / Germany Stavros J.Baloyannis / Greece Maciej Krawczyk / Poland Ovidiu Băjenaru / Romania Simone Lang / Germany Heinrich Binder / Austria Roberto Maturana / Chile Natan Bornstein / Israel Paule G. Merle / USA Anca Buzoianu / Romania Dafin F. Mureşanu / Romania Rudolph Castellani / USA Gelu Onose / Romania Cornel Cătoi / Romania Józef Opara / Poland Michael Chopp / USA Bogdan O. Popescu / Romania A.V. Ciurea / Romania Cristian D. Popescu / Romania László Csiba / Hungary Peter Riederer / Germany Anna Członkowska / Poland Beata Sániová / Slovakia Vida Demarin / Croatia Jeffrey Schwartz / USA Exuperio Díez-Tejedor / Spain Hari Shanker Sharma / Sweden Mohamed El-Tamawy / Egypt Stephen D. Skaper / Italy Anwar Etribi / Egypt Harry Steinbusch / The Netherlands Antonio Federico / Italy Johannes Thome / UK Ştefan Florian / Romania Emil Toescu / UK Tomasz Gaszyński / Poland László Vécsei / Hungary Andrzej Glabinski / Poland Pieter E. Vos / The Netherlands Vladimir Hachinski / Canada Klaus von Wild/ Germany Hassan S. Hosny / Egypt 5 INTERNATIONAL ORGANIZING COMMITTEE /in alphabetical order Anton Alvarez / Spain Amos Korczyn / Israel Russell J.
    [Show full text]
  • Jumping to Conclusions, Liberal Acceptance and the Bias Against Disconfirmatory Evidence: an Evaluation of Reasoning Deviations in Delusions
    Aus der Klinik für Psychiatrie und Psychotherapie Direktor: Prof. Dr. Dr. Johannes Thome Jumping to Conclusions, Liberal Acceptance and the Bias Against Disconfirmatory Evidence: An Evaluation of Reasoning Deviations in Delusions Inauguraldissertation zur Erlangung des akademischen Grades Doktor der Medizin der Medizinischen Fakultät der Universität Rostock vorgelegt von Manuel Tobias Munz, geb. am 18.02.1982 in Mutlangen aus Kiel Rostock, 2011 Dekan: Prof. Dr. Emil Reisinger 1. Gutachter: Prof. Dr. med. Stefan Teipel Klinik für Psychiatrie und Psychotherapie Universitätsklinikum Rostock Deutsches Zentrum für neurodegenerative Erkrankungen Gehlsheimer Straße 20 18147 Rostock 2. Gutachter: Prof. Dr. phil. Steffen Moritz Klinik für Psychiatrie und Psychotherapie Universitätsklinikum Hamburg-Eppendorf Martinistraße 52 20246 Hamburg 3. Gutachter Prof. Dr. med. Sabine C. Herpertz Klinik für Allgemeine Psychiatrie Zentrum für Psychosoziale Medizin Universitätsklinikum Heidelberg Voßstraße 2 69115 Heidelberg Datum der Verteidigung: 02.Mai 2012 Table of Contents Table of Contents Table of Contents ........................................................................................................................... I List of Figures ............................................................................................................................. IV List of Tables ................................................................................................................................. V 1 General Introduction ............................................................................................................
    [Show full text]
  • Scientific Programe
    ICITY • F AST OU PL N O D R A U T E IO “RoNeuro” N N D OF THE O FOUNDATION N F A T H N SOCIETY FOR THE STUDY OF E Institute for Neurological O I S T O C C AND E NEUROPROTECTION I T E T O Y R P F Research and Diagnostic O O R R U T NEUROPLASTICITY E H N E F S T O U Y D Romanian Academy of Medical Sciences CONGRESS OF THE SOCIETY FOR THE STUDY OF GREECE TRAVEL NEUROPROTECTION AND NEUROPLASTICITY 30 OCTOBERANNIVERSAR - 2 NOVEMBERY 2014 Hilton Hotel | ATHENS | GREECE Athens on on Athens the rise the Overlooking Overlooking Athens is the the is Athens caryatid porch of of porch caryatid the Erechtheion Erechtheion the (421–407 BC), on on BC), (421–407 the north side of of side north the the Acropolis. A A Acropolis. the caryatid is a a is caryatid sculpted female female sculpted figure serving as as serving figure an architectural architectural an support 33 Herald Holland CONGRESS OF THE SOCIETY FOR THE STUDY OF NEUROPROTECTION AND NEUROPLASTICITY 30 OCTOBER - 2 NOVEMBER 2014 Hilton Hotel | ATHENS | GREECE ANNIVERSARY CONGRESS CHAIRMEN Dafin F. Muresanu Professor of Neurology, Chairman Department of Neurosciences “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania President of the Romanian Society of Neurology President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN) Chairman “RoNeuro” Institute for Neurological Research and Diagnostic Natan M. Bornstein Professor of Neurology at the Tel-Aviv University Sackler Faculty of Medicine, Israel Vice President of the World Stroke Organization (WSO) Head of Stroke Unit at the Tel-Aviv Medical Center Chairman of the Israeli Neurological Association 3 CONGRESS OF THE SOCIETY FOR THE STUDY OF NEUROPROTECTION AND NEUROPLASTICITY 30 OCTOBER - 2 NOVEMBER 2014 Hilton Hotel | ATHENS | GREECE ANNIVERSARY FACULTY /in alphabetical order Leontino Battistin /Italy Mihaela Baciut /Romania Heinrich Binder /Austria Natan Bornstein /Israel Anca Buzoianu /Romania Michael Chopp /USA Matthias Endres /Germany Antonio Federico /Italy Alla Guekht /Russia Jong S.
    [Show full text]
  • EEG Data Quality: Determinants and Impact in a Multicenter Study of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
    brain sciences Article EEG Data Quality: Determinants and Impact in a Multicenter Study of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) Anna Kaiser 1,*, Pascal-M. Aggensteiner 1, Martin Holtmann 2, Andreas Fallgatter 3, Marcel Romanos 4, Karina Abenova 1 , Barbara Alm 5, Katja Becker 6,7 , Manfred Döpfner 8 , Thomas Ethofer 3, Christine M. Freitag 9, Julia Geissler 4, Johannes Hebebrand 10, Michael Huss 11, Thomas Jans 4, Lea Teresa Jendreizik 8, Johanna Ketter 6, Tanja Legenbauer 2, Alexandra Philipsen 12, Luise Poustka 13, Tobias Renner 14, Wolfgang Retz 15,16, Michael Rösler 16, Johannes Thome 17 , Henrik Uebel-von Sandersleben 13, Elena von Wirth 8 , Toivo Zinnow 16, Sarah Hohmann 1, Sabina Millenet 1, Nathalie E. Holz 1, Tobias Banaschewski 1 , Daniel Brandeis 1,18,19,20 and on behalf of the ESCAlife-Consortium † 1 Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany; [email protected] (P.-M.A.); [email protected] (K.A.); [email protected] (S.H.); [email protected] (S.M.); [email protected] (N.E.H.); [email protected] (T.B.); [email protected] (D.B.) 2 LWL-University Hospital for Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, Citation: Kaiser, A.; Aggensteiner, Ruhr University Bochum, 59071 Hamm, Germany; [email protected] (M.H.); P.-M; Holtmann, M.; Fallgatter, A.; [email protected] (T.L.) Romanos, M.; Abenova, K.; Alm, B.; 3 Tübingen University Hospital for Psychiatry and Psychotherapy, 72076 Tübingen, Germany; Becker, K.; Döpfner, M.; Ethofer, T.; [email protected] (A.F.); [email protected] (T.E.) 4 et al.
    [Show full text]
  • Circadian Rhythms and Attention Deficit Hyperactivity Disorder: the What
    Progress in Neuro-Psychopharmacology & Biological Psychiatry 67 (2016) 74–81 Contents lists available at ScienceDirect Progress in Neuro-Psychopharmacology & Biological Psychiatry journal homepage: www.elsevier.com/locate/pnp Review Circadian rhythms and attention deficit hyperactivity disorder: The what, the when and the why Andrew N. Coogan a,⁎,AlisonL.Bairdb, Aurel Popa-Wagner c, Johannes Thome c a Maynooth University Department of Psychology, National University of Ireland, Maynooth, Ireland b Department of Psychiatry, University of Oxford, Oxford, UK c Department of Psychiatry, School of Medicine, University of Rostock, Germany article info abstract Article history: Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental condition characterised by Received 30 October 2015 impulsivity, inattention and hyperactivity. Aside from these core psychopathologies, sleep disturbances are Received in revised form 11 January 2016 found to be highly comorbid with ADHD, and indeed dysregulated sleep may contribute to some of the symptoms Accepted 13 January 2016 of the disorder. It is not clear how sleep disturbances come to be so common in ADHD, but one putative mecha- Available online 15 January 2016 nism is through the circadian timekeeping system. This system underpins the generation of near 24-hour rhythms in a host of physiological, behavioural and psychological parameters, and is a key determinant of the Keywords: ADHD sleep/wake cycle. In this paper we review the evidence for sleep and circadian rhythm disturbance in ADHD, ex- Circadian amine the possible mechanistic links between these factors and the disorder and discuss future directions Sleep through which the circadian clock can be targetted for ADHD symptom relief. © 2016 Elsevier Inc.
    [Show full text]
  • Traumatic Brain Injury
    Traumatic Brain Injury New Directions in Research and Therapies in Traumatic Brain Injury Expert review: Johannes Thome1 and Dafin F Muresanu2 1. Director and Chair, Clinic and Policlinic for Psychiatry and Psychotherapy, University of Rostock, Germany; 2. Chairman, Department of Clinical Neurosciences, Iuliu Hatieganu University of Medicine and Pharmacy, Faculty for Medicine Cluj-Napoca, Romania Abstract Traumatic brain injury (TBI) is a significant cause of disability and death and its incidence is rising in some specific populations. TBI can result in various disabilities, cognitive problems and psychiatric disorders, depending on the location of the injury and premorbid patient conditions. Effective pharmacological and surgical treatments, however, are currently limited. Most randomised clinical trials for TBI treatments carried out to date have failed to show significant benefits. Initiatives such as the TRACK-TBI have highlighted the large variability in TBI treatment quality at different hospitals and widely differing death rates. This stimulated the establishment of the International Initiative for TBI Research (InTIBR), which aims to improve disease characterisation and patient management. The development of effective treatments for TBI and their evaluation requires an understanding of the complex neuroregenerative processes that follow an injury. In the case of haematoma in TBI, decompressive craniectomy can be a life-saving intervention but must be performed rapidly. The neurotrophic agent, Cerebrolysin®, acts by mimicking neurotrophic factors (NTFs) and by stimulating the endogenous production of NTF in brain tissue. Experimental models show that this drug increases neurogenesis following TBI but these findings need to be converted into clinical practice. The potential of Cerebrolysin in TBI was demonstrated in a large retrospective cohort trial in Romania (n=7,769 adults).
    [Show full text]
  • The Collateral Damage of the COVID-19 Outbreak on Mental Health and Psychiatry
    International Journal of Environmental Research and Public Health Article The Collateral Damage of the COVID-19 Outbreak on Mental Health and Psychiatry Frederick A. J. Simon * , Maria Schenk, Denise Palm, Frank Faltraco and Johannes Thome Clinic and Polyclinic for Psychiatry and Psychotherapy, University of Rostock, 18147 Rostock, Germany; [email protected] (M.S.); [email protected] (D.P.); [email protected] (F.F.); [email protected] (J.T.) * Correspondence: [email protected] Abstract: The potential consequences of the COVID-19 outbreak are multifarious and remain largely unknown. Deaths as a direct result of the condition are already in the millions, and the number of indirect deaths is likely to be even higher. Pre-existing historical inequalities are compounded by the virus, driving increased rates of infection and deaths amongst people who use drugs and alcohol, those belonging to racial-ethnic minority groups, poorer communities, LBGTQ+ populations, healthcare workers, and other members of the care economy; all of whom are already at increased risk of adverse mental health effects. In this paper we suggest that a central role of mental health practitioners is advocacy: both for people who use psychiatric services and for those who, due to the effects of the pandemic, are at an increased risk of needing to do so. Keywords: psychiatry; SARS-CoV-2; COVID-19; stigma; discrimination; disparities Citation: Simon, F.A.J.; Schenk, M.; Palm, D.; Faltraco, F.; Thome, J. The Collateral Damage of the COVID-19 1. Introduction Outbreak on Mental Health and Although the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is only Psychiatry.
    [Show full text]
  • The AMDP System
    The AMDP System Matthew R. Broome Manual for Assessment Ronald Bottlender and Documentation of Michael Rösler Rolf-Dieter Stieglitz Psychopathology in (Editors) Psychiatry 9th edition The AMDP System This document is for personal use only. Reproduction or distribution is not permitted. From M. R. Broome, R. Bottlender, M. Rösler, & R.-D. Stieglitz: The AMDP System (ISBN 9781616765422) © 2018 Hogrefe Publishing. About the Editors Matthew R. Broome, PhD, MRCPsych, is Professor of Psy- chiatry and Youth Mental Health and Director at the Institute for Mental Health at the University of Birmingham, UK and Senior Clinical Research Fellow in the Department of Psychiatry and Faculty of Philosophy at the University of Oxford, UK. Matthew is a founding member of the Maudsley Philosophy Group. Matthew’s research interests include the prodromal phase of psychosis, delusion formation, functional neuroimaging, the role of GABA in psychotic symptoms, mood instability, early intervention services, and the philosophy of psychiatry. Ronald Bottlender, MD, PhD, is the Clinical Director of the Department of Psychiatry and Psychotherapy at Märkische Kliniken, Lüdenscheid, Germany, assistant professor at the Uni- versity of Bochum and lecturer at the University of Bonn, Ger- many. He has held positions as consultant psychiatrist and sen- ior lecturer at Ludwig-Maximilians-University of Munich, Germany and East London NHS Foundation Trust and Queen Mary University of London, UK. He has published more than 100 peer reviewed articles on psychosis, affective disorders, amongst others. Michael Rösler, MD, PhD, is the Head of the Institute of foren- sic Psychiatry at Homburg/Saarland, Germany and Emeritus Pro- fessor at the University of the Saarland, Germany.
    [Show full text]
  • Program.Indd
    ICITY • F AST OU PL N O D R A U T E IO “RoNeuro” N N D OF THE O FOUNDATION N F A T H N SOCIETY FOR THE STUDY OF E Institute for Neurological O I S T O C C AND E NEUROPROTECTION I T E T O Y R P F Research and Diagnostic O O R R U T NEUROPLASTICITY E H N E F S T O U Y D Romanian Academy of Medical Sciences CONGRESS OF THE SOCIETY FOR THE STUDY OF GREECE GREECE TRAVEL TRAVEL NEUROPROTECTION AND NEUROPLASTICITY 30 OCTOBERANNIVERSAR - 2 NOVEMBERY 2014 Hilton Hotel | ATHENS | GREECE Athens on on Athens the rise the Overlooking Overlooking Athens is the the is Athens caryatid porch of of porch caryatid the Erechtheion Erechtheion the (421–407 BC), on on BC), (421–407 the north side of of side north the the Acropolis. A A Acropolis. the caryatid is a a is caryatid sculpted female female sculpted figure serving as as serving figure an architectural architectural an support 33 Herald Holland CONGRESS OF THE SOCIETY FOR THE STUDY OF NEUROPROTECTION AND NEUROPLASTICITY 30 OCTOBER - 2 NOVEMBER 2014 Hilton Hotel | ATHENS | GREECE ANNIVERSARY CONGRESS CHAIRMEN Dafi n F. Muresanu Professor of Neurology, Chairman Department of Neurosciences “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania President of the Romanian Society of Neurology President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN) Chairman “RoNeuro” Institute for Neurological Research and Diagnostic Natan M. Bornstein Professor of Neurology at the Tel-Aviv University Sackler Faculty of Medicine, Israel Vice President of the World Stroke Organization (WSO) Head of Stroke Unit at the Tel-Aviv Medical Center Chairman of the Israeli Neurological Association 3 CONGRESS OF THE SOCIETY FOR THE STUDY OF NEUROPROTECTION AND NEUROPLASTICITY 30 OCTOBER - 2 NOVEMBER 2014 Hilton Hotel | ATHENS | GREECE ANNIVERSARY FACULTY /in alphabetical order Leontino Battistin /Italy Mihaela Baciut /Romania Heinrich Binder /Austria Natan Bornstein /Israel Anca Buzoianu /Romania Michael Chopp /USA Matthias Endres /Germany Antonio Federico /Italy Alla Guekht /Russia Jong S.
    [Show full text]
  • Neurotrophic Factor-Related Gene Polymorphisms and Adult Attention Deficit Hyperactivity Disorder (ADHD) Score in a High-Risk Male Population Alex C
    American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 147B:1476–1480 (2008) Neurotrophic Factor-Related Gene Polymorphisms and Adult Attention Deficit Hyperactivity Disorder (ADHD) Score in a High-Risk Male Population Alex C. Conner,1,2 Christian Kissling,1 Edward Hodges,1 Regina Hu¨ nnerkopf,1 R. Marc Clement,1 Edward Dudley,1 Christine M. Freitag,3 Michael Ro¨ sler,4 Wolfgang Retz,4 and Johannes Thome1* 1Department of Psychiatry, Institute of Life Science, The School of Medicine, University of Wales Swansea, Swansea, UK 2Warwick Medical School, Warwick University, Coventry, UK 3Department of Child and Adolescent Psychiatry, Saarland University, Homburg, Germany 4Institute for Forensic Psychology and Psychiatry, Saarland University, Homburg, Germany Adult attention deficit hyperactivity disorder KEY WORDS: neurotrophic factor; single nucleo- (ADHD) is a widely under-reported but never- tide polymorphisms; genetic asso- theless common condition with a clear heritable ciation; synaptic vesicle protein; component. Several genes have been proposed to ADHD play a role in the childhood onset of this neuro- developmental disorder; however, association studies of persistence of ADHD into adulthood Please cite this article as follows: Conner AC, Kissling have rarely been performed. Neurotrophic factors C, Hodges E, Hu¨ nnerkopf R, Clement RM, Dudley E, (NTFs) are known to be involved in several aspects Freitag CM, Ro¨ sler M, Retz W, Thome J. 2008. Neuro- of neuronal development and neural plasticity trophic Factor-Related Gene Polymorphisms and Adult in adults. They have also been linked, parti- Attention Deficit Hyperactivity Disorder (ADHD) Score cularly through brain-derived neurotrophic fac- in a High-Risk Male Population. Am J Med Genet tor (BDNF) interaction with dopamine transport, Part B 147B:1476–1480.
    [Show full text]
  • Handbook for Attention Deficit Hyperactivity Disorder in Adults Handbook for Attention Deficit Hyperactivity Disorder in Adults
    Handbook for attention deficit hyperactivity disorder in adults Handbook for attention deficit hyperactivity disorder in adults UK Adult ADHD Network (UKAAN) Philip Asherson (UKAAN President) Susan Young (UKAAN Vice President) Marios Adamou Blanca Bolea David Coghill Gisli Gudjonsson James Kustow Ulrich Müller Mark Pitts Johannes Thome www.ukaan.org Published by Springer Healthcare Ltd, 236 Gray’s Inn Road, London, WC1X 8HB, UK. www.springerhealthcare.com © 2013 Springer Healthcare, a part of Springer Science+Business Media. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the copyright holder. British Library Cataloguing-in-Publication Data. A catalogue record for this book is available from the British Library. ISBN 978-1-908517-50-0 Although every effort has been made to ensure that drug doses and other information are presented accurately in this publication, the ultimate responsibility rests with the prescribing physician. Neither the publisher nor the authors can be held responsible for errors or for any consequences arising from the use of the information contained herein. Any product mentioned in this publication should be used in accordance with the prescribing information prepared by the manufacturers. No claims or endorsements are made for any drug or compound at present under clinical investigation. Project editor: Katrina Dorn Designer:
    [Show full text]
  • Biomarkers for Attention-Deficit/Hyperactivity Disorder (ADHD)
    The World Journal of Biological Psychiatry ISSN: 1562-2975 (Print) 1814-1412 (Online) Journal homepage: http://www.tandfonline.com/loi/iwbp20 Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD Johannes Thome, Ann-Christine Ehlis, Andreas J. Fallgatter, Kerstin Krauel, Klaus W. Lange, Peter Riederer, Marcel Romanos, Regina Taurines, Oliver Tucha, Marat Uzbekov & Manfred Gerlach To cite this article: Johannes Thome, Ann-Christine Ehlis, Andreas J. Fallgatter, Kerstin Krauel, Klaus W. Lange, Peter Riederer, Marcel Romanos, Regina Taurines, Oliver Tucha, Marat Uzbekov & Manfred Gerlach (2012) Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD, The World Journal of Biological Psychiatry, 13:5, 379-400, DOI: 10.3109/15622975.2012.690535 To link to this article: http://dx.doi.org/10.3109/15622975.2012.690535 Published online: 27 Jul 2012. Submit your article to this journal Article views: 470 View related articles Citing articles: 1 View citing articles Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=iwbp20 Download by: [Bibliothek der MedUniWien], [Professor Siegfried Kasper] Date: 25 May 2016, At: 02:36 The World Journal of Biological Psychiatry, 2012; 13: 379–400 ORIGINAL INVESTIGATION Biomarkers for attention-defi cit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD JOHANNES THOME 1,2 , ANN-CHRISTINE EHLIS 3 , ANDREAS J. FALLGATTER 3 , KERSTIN KRAUEL 4 , KLAUS W.
    [Show full text]